[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  Third Floor Capital [@3rdFloorCapital](/creator/twitter/3rdFloorCapital) on x XXX followers Created: 2025-07-09 15:05:30 UTC For everyone saying the $VRNA buyout confirms the return of the Biotech Golden Age and wants to play it beyond going long dirt cheap biotechs (you should be doing this as well), $TKNO is an interesting beneficiary. I've written about it in detail before but the TLDR is that they are in the life sci supply chain, have a unique value prop for SMID bios, and are inflecting to profitability. Huge beneficiary if sentiment, funding and R&D spend inflects, and not very expensive. XXXXX engagements  **Related Topics** [prop](/topic/prop) [$tkno](/topic/$tkno) [acquisition](/topic/acquisition) [$vrna](/topic/$vrna) [Post Link](https://x.com/3rdFloorCapital/status/1942963329049174310)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Third Floor Capital @3rdFloorCapital on x XXX followers
Created: 2025-07-09 15:05:30 UTC
For everyone saying the $VRNA buyout confirms the return of the Biotech Golden Age and wants to play it beyond going long dirt cheap biotechs (you should be doing this as well), $TKNO is an interesting beneficiary.
I've written about it in detail before but the TLDR is that they are in the life sci supply chain, have a unique value prop for SMID bios, and are inflecting to profitability. Huge beneficiary if sentiment, funding and R&D spend inflects, and not very expensive.
XXXXX engagements
Related Topics prop $tkno acquisition $vrna